Physician profile
Richard Derner
NPI 1932177607
$211,539.63
in general payments reported to CMS, 2019-2025
37 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $21K · 2021: $72K · 2022: $43K · 2023: $29K · 2024: $7,591 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Royalty Or License: $21K · Travel and Lodging: $3,341 · Food and Beverage: $3,326 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,432.84 |
| Royalty Or License | $21,022.92 |
| Travel and Lodging | $3,340.73 |
| Food and Beverage | $3,325.59 |
| Education | $190.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flower Orthopedics Coporation | $77,814.68 | 2019-2025 | Fibula Nail, 4.5mm X 180mm, Titanium, Flex-Thread, Zero Profile Interlocking Cortex Screw, 2.7mm X 14mm, T8, Flex-Thread, Fibula Nail, 3.5mm X 130mm, Titanium, Flex-Thread |
| Medshape, INC. | $57,521.43 | 2021 | |
| New Standard Device, LLC Dba Metalogix | $43,795.85 | 2022-2025 | |
| Anika Therapeutics, INC. | $10,106.05 | 2022-2023 | Tactoset, X-Twist, Fna Products |
| Fusion Orthopedics USA, LLC | $9,806.33 | 2025 | Metalogix |
| Zimmer Biomet Holdings, INC. | $4,344.81 | 2019-2024 | Affixus, Stratum Foot Plating System |
| Stryker Corporation | $4,173.17 | 2019-2025 | Valor, Prophecy, Inbone |
| Ossio INC | $1,594.33 | 2023 | |
| Ortho Solutions INC | $309.08 | 2023-2024 | |
| Wright Medical Technology, INC. | $268.10 | 2019-2020 | |
| Depuy Synthes Sales INC. | $244.73 | 2020-2024 | Hammerlock, Na |
| Linvatec Corporation | $224.13 | 2023 | Allograft Tissue, Quantum, Colink 2 |
| Smith+Nephew, INC. | $173.17 | 2019-2025 | Grafix |
| Biocomposites INC | $159.06 | 2024-2025 | Stimulan |
| Trilliant Surgical LLC. | $149.26 | 2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $102.47 | 2020-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $91.90 | 2025 | |
| Organogenesis INC. | $83.76 | 2021-2023 | Puraply |
| Integra Lifesciences Corporation | $78.82 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bonalive INC | $52.59 | 2025 | |
| Horizon Therapeutics Plc | $47.93 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $47.25 | 2022-2023 | Nuzyra |
| Novastep INC. | $43.78 | 2025 | Nexis |
| Supreme Orthopedic Systems, LLC | $37.79 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $34.86 | 2019-2024 | Exparel, Iovera |
| Convatec INC. | $31.22 | 2023 | |
| Hikma Pharmaceuticals USA | $29.29 | 2021 | |
| Orthofix Medical, INC. | $24.12 | 2021-2024 | Accelstim |
| Averitas Pharma INC. | $22.27 | 2025 | Qutenza |
| Dynasplint Systems INC. | $21.63 | 2023 | Dynasplint |
| Progenacare Global, LLC | $18.70 | 2024 | |
| Ermi LLC | $16.76 | 2022 | |
| Merck Sharp & Dohme LLC | $16.66 | 2019 | |
| Medtronic, INC. | $15.97 | 2024 | Intellis Adaptivestim |
| Nabriva Therapeutics, Plc | $15.16 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.46 | 2023 | Seglentis |
| Kerecis Limited | $8.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$125,195.76 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Derner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.